RxDoctor Payments Data

Emily Bengston, PA

Physician Assistant · Hickory Creek, TXNPI 1174016539

Payments from drug & device makers

$497in general payments, 2019–2025

Across 21 payments — averaging $23.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceutical Holding Company Ltd.$109
  • Novo Nordisk$98
  • Esperion Therapeutics, Inc.$93
  • Exact Sciences$40
  • Biohaven Pharmaceuticals, Inc.$22
  • Amarin Pharma, Inc.$20
  • plus $114 from 7 others

What the payments were for

  • Food & beverage$497100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$497 in reported general payments places this provider in the 50th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$57,234
Medicare patients
234
Services billed
1,162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide49$87,684
MounjaroTirzepatide33$53,851
TrulicityDulaglutide23$40,830
JardianceEmpagliflozin26$35,862
XareltoRivaroxaban11$15,789
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$15,305
Levothyroxine Sodium166$2,359
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$2,171
Albuterol Sulfate HfaAlbuterol Sulfate68$2,077
Atorvastatin Calcium244$1,998
Rosuvastatin Calcium175$1,742
Omeprazole87$1,734
Duloxetine Hcl38$1,734
Gabapentin74$1,456
Ventolin HfaAlbuterol Sulfate23$1,278

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$98$87,68449 claims
GSKTrelegy Ellipta$16$15,30516 claims
AbbVieSynthroid$15$71612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Hickory Creek

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →